Cineverse Signs Highlander Franchise Digital Rights Deal with Davis-Panzer Productions
Get Alerts CNVS Hot Sheet
Join SI Premium – FREE
Popular Action- Adventure Fantasy Films and Television Series Available on
Cineverse Streaming Services and Other Digital Platforms
Under the multi-year and multi-territory agreement, Cineverse has the rights to nine movie and television series titles for its streaming services – including Cineverse and Midnight Pulp – and distribution over other digital platforms and streaming services.
Cineverse's catalog features the original Highlander film, all six seasons of Highlander: The Series, and its spin-off, Highlander: The Raven. Additionally, the collection includes a diverse selection of films produced by Davis-Panzer, such as Cat Chaser, O'Hara's Wife, The Osterman Weekend,
Highlander, the iconic action-adventure fantasy franchise and pop culture phenomenon launched in 1986 with the original movie starring
"We are thrilled to continue our partnership with Davis-Panzer Productions and re-imagine new ways to deliver such a valuable IP to its fans," said Cineverse Chief Content Officer
The owners and executive team of Davis Panzer Productions (
ABOUT CINEVERSE
Cineverse (Nasdaq: CNVS) is a next-generation entertainment studio that empowers creators and entertains fans with a wide breadth of content through the power of technology. It has developed a new blueprint for delivering entertainment experiences to passionate audiences and results for its partners with unprecedented efficiency, and distributes more than 71,000 premium films, series, and podcasts. Cineverse connects fans with bold, authentic, independent stories. Properties include the highest-grossing non-rated film in
Press Contacts:
For Media
The Lippin Group for Cineverse, [email protected]
For Investors
View original content to download multimedia:https://www.prnewswire.com/news-releases/cineverse-signs-highlander-franchise-digital-rights-deal-with-davis-panzer-productions-302371737.html
SOURCE Cineverse Corp.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ericsson reports second quarter results 2026
- FDA approves Leqembi Iqlik® (lecanemab-irmb) subcutaneous injection as a starting dose for early Alzheimer's disease
- WISeKey Reports Unaudited Preliminary H1 2026 Key Metrics; Revenue Up 115%, FY 2026 Guidance Reaffirmed
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share